Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-stage Small Cell Lung Cancer (LS-SCLC)”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Looking for participantsNCT06911606
What this trial is testing

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
SCLC, Limited Stage
Guangdong Provincial People's Hospital 45
Testing effectiveness (Phase 2)UnknownNCT05483543
What this trial is testing

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381543
What this trial is testing

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Who this might be right for
Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 76
Large-scale testing (Phase 3)Looking for participantsNCT06095583
What this trial is testing

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Shanghai Junshi Bioscience Co., Ltd. 756
Early research (Phase 1)Study completedNCT00062322
What this trial is testing

Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Large-scale testing (Phase 3)UnknownNCT02990780
What this trial is testing

Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

Who this might be right for
SCLC
Shanghai Chest Hospital 266
Testing effectiveness (Phase 2)UnknownNCT02738723
What this trial is testing

SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC

Who this might be right for
Small Cell Lung Cancer
Third Military Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05443646
What this trial is testing

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Who this might be right for
Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Not applicableStudy completedNCT02394548
What this trial is testing

Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung CarcinomaSmall Cell Lung Carcinoma
Massachusetts General Hospital 27
Large-scale testing (Phase 3)Active Not RecruitingNCT04624204
What this trial is testing

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 672
Testing effectiveness (Phase 2)Active Not RecruitingNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06914050
What this trial is testing

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Who this might be right for
Lung Cancer, Small CellLimited-stage Small Cell Lung Cancer (LS-SCLC)
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06773910
What this trial is testing

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Who this might be right for
Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07357532
What this trial is testing

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

Who this might be right for
Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute 44
Large-scale testing (Phase 3)Active Not RecruitingNCT03811002
What this trial is testing

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Lung Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 544
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055581
What this trial is testing

Durvalumab as Consolidation for Patients LS-SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Qian Chu 100
Large-scale testing (Phase 3)Looking for participantsNCT05623267
What this trial is testing

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Who this might be right for
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University 346
Large-scale testing (Phase 3)UnknownNCT04691063
What this trial is testing

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 486
Testing effectiveness (Phase 2)Looking for participantsNCT06943235
What this trial is testing

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Small Cell Lung Cancer
Fudan University 60
Load More Results